Table 3.
CVD, CHD and stroke follow-up data of the study group as percentages (number of events)
| Grade of liver brightness | Total | 0 (n=720) | 1 (n=124) | 2 (n=144) | p Value |
|---|---|---|---|---|---|
| Non-fatal events | |||||
| CVD | 11.6% (115) | 9.9% (71) | 16.1% (20) | 16.7% (24) | <0.05 |
| CHD | 7.8% (77) | 6.5% (47) | 11.3% (14) | 11.1% (16) | NS |
| Stroke | 5.0% (49) | 4.2% (30) | 8.1% (10) | 6.2% (9) | NS |
| Fatal events | |||||
| CVD | 5.5% (54) | 3.6% (26) | 8.1% (10) | 12.5% (18) | <0.001 |
| CHD | 4.8% (47) | 3.2% (23) | 7.3% (9) | 10.4% (15) | <0.01 |
| Stroke | 0.8% (8) | 0.6% (4) | 0.8% (1) | 2.1% (3) | NS |
Statistical significances between percentages were measured by using χ2 test. CVD included a major CHD event and stroke (excluding subarachnoid haemorrhage)—whichever of these happened first.
CHD, coronary heart disease; CVD, cardiovascular disease; N, number of participants.